Sen. Bill Cassidy (R-LA), chair of the Senate Health, Education, Labor and Pensions Committee, announced Thursday that he will support Dr. Erica Schwartz’s nomination to lead the Centers for Disease Control and Prevention [1].
This endorsement is critical because Cassidy leads the committee responsible for vetting the nominee before the full Senate can vote. His support signals a path forward for Schwartz to take control of the nation's primary public health agency during a period of scrutiny over vaccine confidence.
Cassidy said the announcement during a committee hearing in Washington, D.C., on July 23, 2026 [1, 2]. He said the decision followed nearly a week of uncertainty [3]. The senator emphasized the necessity of a CDC leader who can maintain public trust in immunization programs to prevent outbreaks.
"CDC needs someone who understands that the way to prevent vaccine‑preventable diseases is to reassure the public that vaccines are safe and effective," Cassidy said [1].
Throughout the confirmation process, questions had surfaced regarding the nominee's stance on vaccines. However, Cassidy said he is confident that Schwartz knows what she is doing and will stand up for the science [2]. By advancing the nomination, Cassidy ensures that the process moves toward a final floor vote.
"After nearly a week of uncertainty, I will support Dr. Erica Schwartz’s nomination," Cassidy said [3].
The move comes as the administration seeks to fill key health leadership roles. The CDC remains a focal point for debates over the intersection of scientific guidance and public policy, a balance Cassidy suggested Schwartz is equipped to maintain.
“"CDC needs someone who understands that the way to prevent vaccine‑preventable diseases is to reassure the public that vaccines are safe and effective."”
The support of the Senate Health Committee chair removes a significant legislative hurdle for Dr. Erica Schwartz. By explicitly linking his support to the nominee's ability to defend vaccine safety, Cassidy is attempting to insulate the CDC's scientific credibility from political volatility, ensuring the agency retains its authority to manage preventable diseases.
